BMY vs RGEN
Bristol Myers Squibb vs Repligen — AI-powered side-by-side comparison
| Metric | BMY | RGEN |
|---|---|---|
| AI Score | 56 | 62 |
| Price | $65.30 | $141.09 |
| P/E Ratio | 14.39× | 190.55× |
| ROE | 0.4% | 0.0% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.7% | 0.5% |
| Debt / Equity | 1.93× | 0.33× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 79.6 | 50.9 |
| Beta | 0.235 | 1.06 |
| Expected Upside | +1.4% | +5.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
BMY Full Analysis
RGEN Full Analysis